Siemens Healthineers AG (SHLd)
FRA • Healthcare
September 10, 2026 at 12:52 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every €100 in revenue, Siemens Healthineers AG keeps €12 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Siemens Healthineers topped consensus on adjusted EPS in the third fiscal quarter of 2026, reported July 31, as adjusted EPS of EUR 0.69 against a EUR 0.52 estimate, +33%, came in above expectations while revenue of EUR 5.764 billion versus EUR 5.667 billion consensus, +1.7%, was in line and rose 1.8% from a year ago. Gross margin was near 43% and operating margin about 18%, with operating income around EUR 1.0 billion. Net income rose 21.2% to about EUR 669 million from EUR 552 million a year earlier, and adjusted EPS was up 6.5% from EUR 0.65. Operating cash flow came to EUR 1.179 billion. Next-period consensus calls for EPS of EUR 0.69 on revenue of EUR 6.799 billion.
About Siemens Healthineers AG
Siemens Healthineers AG trades on XETRA under SHL.DE and operates in healthcare as a maker of medical devices, diagnostics, and treatment technology. In FY2025, the company generated EUR 23.4 billion in revenue. Its business spans diagnostic imaging, laboratory and point-of-care testing, cancer-care systems, and tools used in minimally invasive procedures.
Today's Snapshot
So far today, SHLd is trading slightly higher at 38.78, in line with a flat sector. Siemens Healthineers invested nearly $44 million to expand PET/CT production in Tennessee.
Trading Volume
Below 10d avg (697.7K)
79.5K
vs S&P 500 Today
Outperforming Market
+0.71%
Updated: September 10, 2026 at 10:34 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$37.64 - $39.74Sell
- RSI (14)50.79Neutral
- Stochastic %K (14, 3, 3)22.16Neutral
- MACD Level (12, 26)0.24Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.